Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study).

Stephanie Korn,Katrin Milger,Dirk Skowasch,Christian Schulz,Cordula Mohrlang,Martin Wernitz,Thomas Paulsson,Michael Hennig,Roland Buhl

Journal of asthma and allergy（2023）

引用 2|浏览6

暂无评分

摘要

The GAN registry data confirm the effectiveness of mepolizumab in a real-world setting. Treatment benefits are maintained over time. While the asthma of patients treated in routine practice was more severe, the results observed with mepolizumab are broadly consistent with RCTs.

查看译文

关键词

severe asthma, registry, real-world, mepolizumab, patient profile, asthma control

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要